Propylamine

Propylamine

SCHEMBL27795182

CCCN.COc1ccc(OC)c(I)c1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 2/20 0.54
▸ TAAR1 Q96RJ0 1/20 0.54
▸ CA12 O43570 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ CA7 P43166 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ ADRA2A P08913 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ IDO1 P14902 2/20 0.46
▸ HTR2A P28223 1/20 0.44
▸ CYP3A4 P08684 1/20 0.43
▸ AOC3 Q16853 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL481218 0.87 CA12 (0.62) ADRA1ATAAR1CA12CA1CA2
SCHEMBL30776243 0.87 CA12 (0.62) ADRA1ATAAR1CA12CA1CA2
Isopropylamine SCHEMBL28069283 0.81 HTR2A (0.54) ADRA1ATAAR1CA12CA1CA2
Propylamine SCHEMBL27607874 0.80 ADRA1A (0.56) ADRA1ATAAR1CA12CA1CA2
SCHEMBL15515783 0.78 MAPT (0.47) ADRA1ACA12CA1CA2CA7
SCHEMBL15515387 0.78 NQO1 (0.48) CA12CA1CA2CA7CA9
SCHEMBL22118201 0.77 CA12 (0.54) ADRA1ATAAR1CA12CA1CA2
SCHEMBL22005062 0.74 F2 (0.49) ADRA1ATAAR1CA12CA1CA2
SCHEMBL7934262 0.72 KDM4E (0.48) TAAR1CA2ALDH1A1MEN1KMT2A
SCHEMBL27933953 0.71 ACHE (0.48) ALDH1A1MAPTKMT2AKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106102836-A Halogen treatment of heart attack and ischemic injury 弗雷德哈钦森癌症研究中心 2016-11-09 — — CN disclosed
CN-102098914-A Novel compositions and methods for treating hyperproliferative diseases ALS MOUNTAIN LLC 2011-06-15 — — CN disclosed
CN-101677971-A The combination of 5-HT2A inverse agonist and antagonist and antipsychotic drug ACADIA PHARM INC 2010-03-24 — — CN disclosed
Send feedback